Newsroom
BioVersys secures CHF 14 million for new clinical study on hospital infections
11.11.2025
Basel-based BioVersys will advance its lead anti-infective candidate BV100 into Phase 2b clinical development with support from We ... more
YQuantum receives CHF 150,000 from Venture Kick to create scalable hardware for the next generation of quantum computers
10.11.2025
YQuantum has obtained CHF 150,000 from Venture Kick to develop miniaturized hardware components for the next generation of quantum ... more
BTRY raises USD 5.7 million to industrialize ultra-thin solid-state batteries
06.11.2025
Swiss startup BTRY AG has closed a USD 5.7 million oversubscribed seed round to scale production of its ultra-thin solid-state bat ... more
Media contacts
For media enquiries, please email our communications team. If you have a general question about Venture Kick please visit our about us page.
Learn more about Venture Kick or download the latest annual report for detailed information.
